Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The study objective is to evaluate the maximum tolerated dose, safety and efficacy of
patupilone in patients with NSCLC who have progressed after prior chemotherapy.